28 September 2022

Precisely targeting heart failure treatments at the underlying molecular cause of an individual patient’s disease is a radical change from current clinical management paradigms. Yet, a growing understanding of the genetic drivers of heart failure are laying the foundations for precision medicine in a disease affecting 64 million people worldwide.¹

Learn more about our ambitious goal to bring precision medicine to well defined heart failure populations so the right drug is available for the right patient at the right time.

1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2017;390(10100):1211-1259.

Read more